Live Breaking News & Updates on Medical Oncology Division

Stay updated with breaking news from Medical oncology division. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Dr Shadman on the Comparative Efficacy of Currently Available BTK Inhibitors in CLL

Mazyar Shadman, MD, MPH, discusses results from a network meta-analysis on the comparative efficacy of BTK inhibitors in relapsed/refractory CLL. ....

Mazyar Shadman , Innovators Network , Fred Hutch Cancer Center , Clinical Research Division , Oncology Division , University Of Washington School Medicine , Innovators Network Endowed Chair , Medical Oncology Division , Washington School ,

BTK Inhibitor Combinations Move to Forefront of CLL Investigations, Conversations

Mazyar Shadman, MD, MPH, details the efficacy of BTK inhibitors in the frontline treatment of CLL as well as safety considerations in the relapsed/refractory setting. ....

United States , North Carolina , University Of Washington , Alan Skarbnik , Mazyar Shadman , American Society Of Hematology Annual Meeting Exposition , Novant Health In Charlotte , International Conference On Malignant Lymphoma , Oncology Division , University Of Washington School Medicine , Innovators Network , Onclive Scientific Interchange , Workshop Chronic Lymphocytic Leukemia , Latest Data , Clinical Practice , Innovators Network Endowed Chair , Clinical Research Division , Fred Hutch Cancer Center , Medical Oncology Division , Washington School , Shows Efficacy , Novant Health , American Society , Hematology Annual Meeting , Safety Considerations With , Noncovalent Inhibition With ,

Pirtobrutinib, Liso-Cel Could Expand Treatment Arsenal for Relapsed/Refractory CLL

Mazyar Shadman, MD, MPH, discusses the evolution of BTK inhibitors in CLL, highlights how treatment patterns have evolved with the continued emergence of data on ibrutinib, acalabrutinib, and zanubrutinib, and expands on how pirtobrutinib and liso-cel could address unmet needs for this patient population. ....

Mazyar Shadman , National Comprehensive Cancer Network , Clinical Research Division , Oncology Division , Hematologic Malignancies At Fred Hutchinson Cancer Center , University Of Washington School Medicine , Medical Oncology Division , Washington School , Hematologic Malignancies , Fred Hutchinson Cancer , B Cell Non Hodgkin Lymphoma , Chronic Lymphocytic Leukemia , Cart Cell Therapy , Liso Cel ,

Strides in GI Cancer Subsets Influence Advances

Tanios S. Bekaii-Saab, MD, highlights the unmet needs in GI malignancies and discusses how interdisciplinary meetings, such as the 20th Annual Meeting of the International Society of Gastrointestinal Oncology, provide the framework for disseminating information and driving innovative advances. ....

United States , Tanioss Bekaii Saab , Weijing Sun , American Association Of Cancer Research Annual Meeting , Oncology Division , University Of Kansas School Medicine , Mayo Clinic College Of Medicine , Physician Education Resource , Annual Meeting , International Society , Gastrointestinal Oncology , Mayo Clinic College , Mayo Clinic , Sprint Professor , Medical Oncology , Medical Oncology Division , Kansas School , Kansas Cancer Center , American Association , Cancer Research Annual Meeting ,

Geneseeq, Brazilian Hospital Partner on Co-establishment of In-house NGS Lab

Geneseeq, Brazilian Hospital Partner on Co-establishment of In-house NGS Lab
businessinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businessinsider.com Daily Mail and Mail on Sunday newspapers.

Sao Paulo , Rio Preto , Santa Catarina , Sao Jose Do Rio Preto , Xue Wu , Daniel Araujo , Mauricio Nogueira , Group Geneseeq Technology Inc , Hospital De , Oncology Division At Hospital De , Geneseeq Technology Inc , Hospital De Base , Sao Jos , Geneseeq Canada , Sao Jose , Medical Director , Medical Oncology Division , Laboratory Director , Jorge Fares , Executive Director ,